Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1986 1
1987 3
1988 14
1989 18
1990 31
1991 30
1992 31
1993 29
1994 45
1995 51
1996 43
1997 40
1998 48
1999 33
2000 40
2001 36
2002 45
2003 53
2004 43
2005 51
2006 42
2007 37
2008 33
2009 53
2010 48
2011 58
2012 61
2013 60
2014 83
2015 110
2016 104
2017 103
2018 112
2019 90
2020 108
2021 98
2022 80
2023 101
2024 99
2025 101
2026 49

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,080 results

Results by year

Filters applied: . Clear all
Page 1
Platelet-Rich Plasma (PRP): Current Applications in Dermatology.
Emer J. Emer J. Skin Therapy Lett. 2019 Sep;24(5):1-6. Skin Therapy Lett. 2019. PMID: 31584784 Free article. Review.
Platelet-rich plasma (PRP) is an autologous serum containing high concentrations of platelets and growth factors. PRP continues to evolve as an important treatment modality with many applications in dermatology, particularly in the areas of hair restor …
Platelet-rich plasma (PRP) is an autologous serum containing high concentrations of platelets and growth factors. PRP c …
Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development.
Gentile P, Garcovich S. Gentile P, et al. Cells. 2019 May 16;8(5):466. doi: 10.3390/cells8050466. Cells. 2019. PMID: 31100937 Free PMC article. Review.
The potential regenerative instruments and functions of various cell populaces in the hair regrowth process are discussed. The addition of Wnt signaling in dermal papilla cells is considered a key factor in stimulating hair growth. Mesenchymal stem cell-derived s …
The potential regenerative instruments and functions of various cell populaces in the hair regrowth process are discussed. The addition of W …
A prospective study of hair transplantation combined with concentrated growth factors for the treatment of androgenetic alopecia.
Wang Q, Pang J, Xie K, Wang X, Cao N, Liu G, Wang H. Wang Q, et al. J Dermatolog Treat. 2026 Dec;37(1):2635881. doi: 10.1080/09546634.2026.2635881. Epub 2026 Feb 27. J Dermatolog Treat. 2026. PMID: 41757630 Free article. Clinical Trial.
Follicular Unit Extraction (FUE) provides favorable outcomes even in patients with reduced follicular density. Concentrated Growth Factors (CGF), a third-generation platelet concentrate rich in growth factors (GFs), may enhance follicular …
Follicular Unit Extraction (FUE) provides favorable outcomes even in patients with reduced follicular density. Concentrated Growth …
Comparative efficacy and safety of platelet-rich plasma (PRP), injectable platelet-rich fibrin (i-PRF) and concentrated growth factors (CGF) for female pattern hair loss (FPHL): a prospective multicenter randomized clinical trial.
Li M, Bai Y, Ye Z, Zhang D, He Z, Ge Z, Tan A, Han Y, Chen A, Wang W, Zhuo F. Li M, et al. J Dermatolog Treat. 2026 Dec;37(1):2659498. doi: 10.1080/09546634.2026.2659498. Epub 2026 Apr 27. J Dermatolog Treat. 2026. PMID: 42041234 Free article. Clinical Trial.

The i-PRF group showed the lowest adverse event rate. Vascular endothelial growth factor (VEGF) concentration demonstrated a significant positive correlation with the percentage increase in TAHC (r = 0.527, R(2)=0.278, p < 0.05). ...VEGF levels may play a potenti

…
The i-PRF group showed the lowest adverse event rate. Vascular endothelial growth factor (VEGF) concentration demonstrated a s …
[Psoriasis,Cardiovascular Disease,and Adipokines].
Yu XL, Wu C, Jin HZ. Yu XL, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018 Aug 30;40(4):556-562. doi: 10.3881/j.issn.1000-503X.9793. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018. PMID: 30193612 Review. Chinese.
Similarly,adiponectin plays a protective role in cardiovascular disease,but the role of retina in cardiovascular disease is still controversial. However,the concentrations of leptin,resistin,visfatin,chemerin,and RBP-4 in patients with psoriasis or cardiovascular disease a …
Similarly,adiponectin plays a protective role in cardiovascular disease,but the role of retina in cardiovascular disease is still controvers …
OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005.
Saghari M, Gal P, Gilbert S, Yateman M, Porter-Brown B, Brennan N, Quaratino S, Wilson R, Grievink HW, Klaassen ES, Bergmann KR, Burggraaf J, van Doorn MBA, Powell J, Moerland M, Rissmann R. Saghari M, et al. Clin Pharmacol Ther. 2022 May;111(5):1121-1132. doi: 10.1002/cpt.2539. Epub 2022 Mar 1. Clin Pharmacol Ther. 2022. PMID: 35092305 Free PMC article. Clinical Trial.
Sixty-four healthy male subjects (26.5 6.0 years) were randomized to single doses of 0.006, 0.018, or 0.05 mg/kg, or multiple doses of 0.15, 0.45, 1.35, 4, or 12 mg/kg KY1005, or placebo (6:2). Serum KY1005 concentrations were measured. Antibody responses upon KLH and TT …
Sixty-four healthy male subjects (26.5 6.0 years) were randomized to single doses of 0.006, 0.018, or 0.05 mg/kg, or multiple doses of 0.1 …
Evaluation of the safety and efficacy of concentrated growth factors for hair growth promotion in androgenetic alopecia patients: A retrospective single-centre, single-arm study.
Cao S, Zhu M, Bi Y. Cao S, et al. J Cosmet Dermatol. 2024 Dec;23(12):4051-4056. doi: 10.1111/jocd.16519. Epub 2024 Aug 21. J Cosmet Dermatol. 2024. PMID: 39169643 Free PMC article.
OBJECTIVE: This study was designed to evaluate the safety and efficacy of injections of concentrated growth factors (CGF) for hair growth promotion in androgenetic alopecia (AGA) patients. ...RESULTS: At 3 months after the first injection, the hair den …
OBJECTIVE: This study was designed to evaluate the safety and efficacy of injections of concentrated growth factors (CG …
The pathogenesis of dermatomyositis.
Thompson C, Piguet V, Choy E. Thompson C, et al. Br J Dermatol. 2018 Dec;179(6):1256-1262. doi: 10.1111/bjd.15607. Epub 2017 May 24. Br J Dermatol. 2018. PMID: 28542733 Review.
This review looks at the many different factors thought to play a role in idiopathic inflammatory myopathies (IIM), concentrating mainly on the dermatomyositis (DM) subtype. ...This review goes on to address other attributing factors such as genetic associati …
This review looks at the many different factors thought to play a role in idiopathic inflammatory myopathies (IIM), concentrating …
Innovative use of concentrated growth factors combined with corticosteroids to treat discoid lupus erythematosus alopecia: A case report.
Fang H, Liu Q, Cheng T, Yang C, Wu R, Yang Z, Yang D. Fang H, et al. J Cosmet Dermatol. 2021 Aug;20(8):2538-2541. doi: 10.1111/jocd.13904. Epub 2021 Jan 6. J Cosmet Dermatol. 2021. PMID: 33356005
Early diagnosis and timely treatment can achieve hair regeneration and prevent further disease progression. Concentrated growth factor, a novel autologous plasma extract, contains various growth factors that could promote tissue regeneration. In this a …
Early diagnosis and timely treatment can achieve hair regeneration and prevent further disease progression. Concentrated growth …
Secukinumab in the Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Pooled Pharmacokinetics and Safety Results From the SUNSHINE and SUNRISE Phase 3 Studies.
Alavi A, Reguiai Z, Jemec GBE, Gottlieb AB, Wozniak MB, Uhlmann L, Fan H, Llobet Martinez A, Bruin G, Thomas N, Alarcon I, Bieth B, Ravichandran S, Kimball AB. Alavi A, et al. Int J Dermatol. 2026 Feb;65(2):289-298. doi: 10.1111/ijd.70025. Epub 2025 Aug 21. Int J Dermatol. 2026. PMID: 40839197 Free PMC article. Clinical Trial.
A population PK model assessed the effects of body weight, disease severity, and baseline hsCRP on secukinumab serum concentration. Exposure-response analysis assessed the relationship between predicted PK and HS clinical response [HiSCR]. ...Higher body weight, disease se …
A population PK model assessed the effects of body weight, disease severity, and baseline hsCRP on secukinumab serum concentration. E …
2,080 results